Therapeutic Hypothermia Market is projected to reach USD 458.11 million by 2031 | Phoenix Medical Systems, Gentherm Medicals, Terumo Cardiovascular Systems Corporation, Stryker Corporation, Aspen System

The global therapeutic hypothermia market was valued at USD 288 million in 2023 and is projected to reach USD 458.11 million by 2031, registering a compound annual growth rate (CAGR) of 6.1% during the forecast period from 2024 to 2031.

The Therapeutic Hypothermia Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/therapeutic-hypothermia-market?sg

Therapeutic Hypothermia Market Overview:

Therapeutic hypothermia, also known as targeted temperature management, is an active medical intervention designed to deliberately lower and maintain a patient's body temperature for a controlled period. This approach is used to improve recovery outcomes, particularly after incidents where blood flow to the brain has been interrupted such as during cardiac arrest or ischemic stroke caused by a blood clot.

The primary goal of therapeutic hypothermia is to minimize tissue damage by reducing the body's metabolic rate and inflammatory responses, thereby protecting the brain and other vital organs. In recent years, research has highlighted the therapeutic benefits of this technique, and further advancements are being made by combining hypothermia with other neuroprotective strategies. Ongoing studies are also deepening our understanding of the biological mechanisms behind hypothermia's protective effects.

Therapeutic Hypothermia Industry Trends:

Rising Prevalence of Neurological and Cardiovascular Diseases Driving Market Growth

The global therapeutic hypothermia market is witnessing strong growth, largely fueled by the increasing incidence of neurological and cardiovascular disorders. These conditions often require advanced neuroprotective interventions, where therapeutic hypothermia plays a critical role in improving patient outcomes.

According to data from the World Heart Federation, published on May 20, 2023, the number of deaths caused by cardiovascular diseases has risen sharply-from 12.1 million in 1990 to 20.5 million in recent years. Contributing factors include rising levels of air pollution, widespread tobacco use, and a growing prevalence of high blood pressure.

In parallel, neurological disorders are also on the rise. A World Health Organization report from March 2024 highlights an 18% increase in neurological diseases globally, with over one-third of the population now affected. It is estimated that more than 3 billion people worldwide are living with neurological conditions. While men generally experience a greater burden of disability and health loss from these conditions, certain disorders such as migraines and dementia disproportionately impact women.

This growing disease burden underscores the critical need for effective interventions like therapeutic hypothermia, which is increasingly being adopted to mitigate brain damage and improve survival rates in patients suffering from stroke, cardiac arrest, and other severe neurological events.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/therapeutic-hypothermia-market?sg

Strategic Players Driving the Therapeutic Hypothermia Market Forward: Asahi Kasei Corporation, Becton Dickinson and Company, Shenzhen Comen Medical Instruments Co., Terumo Cardiovascular Systems Corporation, Phoenix Medical Systems, Gentherm Medicals, International Biomedical Ltd., Global Healthcare SG, Stryker Corporation, Aspen Systems.

Research Methodology:

The global Therapeutic Hypothermia Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Therapeutic Hypothermia Market:

By Product Type )Surface Cooling Packs, Surface Heat Exchange Device, Surface Cooling Helmet, Catheter Technology, Cold Fluids Infusion, Others)

By Application (Neurology, Cardiology, Neo-natal Care)

By End-User (Hospitals, Specialty Clinics, Ambulance and Emergency Medical Services, Academic and Research Institutes, Others)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Recent Developments in the Therapeutic Hypothermia Market

BrainCool and Asahi Kasei Corporation Agreement (2023):
In 2023, BrainCool, a medical device company specializing in therapeutic hypothermia systems, entered into a strategic agreement with Japan-based Asahi Kasei Corporation. The partnership focuses on the distribution of cooling systems and cooling pads across the European and U.S. markets, aiming to expand BrainCool's product reach and enhance temperature management solutions globally.

SourceMark Medical and Gentherm Medicals Partnership Expansion (January 2024):
SourceMark Medical announced an expanded partnership with Gentherm Medical in early 2024. Under this agreement, SourceMark serves as the master distributor for several of Gentherm's patient warming solutions in the U.S.

NICE and Aspen Group Collaboration (March 2023):
In March 2023, NICE partnered with Aspen Group to combine NICE's advanced cold compression technology with Aspen's orthopedic bracing products. This collaboration led to the integration of NICE therapy pads with devices such as the Vista Cervical Collar and Horizon 637. The all-in-one system delivers cold therapy and pneumatic compression, helping reduce swelling, support lymphatic drainage, and improve post-surgical or post-injury recovery.

Regional Analysis for Therapeutic Hypothermia Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Therapeutic Hypothermia Market Research Industry:

➠ Who leads the Therapeutic Hypothermia industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Therapeutic Hypothermia market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Therapeutic Hypothermia market growth?

➠ What are the dominant sales and distribution strategies in the Therapeutic Hypothermia industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.